Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

InfuSystem Holdings (INFU) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for InfuSystem Holdings (INFU) over the last 17 years, with Q3 2025 value amounting to $2.6 million.

  • InfuSystem Holdings' Other Operating Expenses fell 1408.59% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.2 million, marking a year-over-year decrease of 1966.14%. This contributed to the annual value of $12.3 million for FY2024, which is 982.85% down from last year.
  • As of Q3 2025, InfuSystem Holdings' Other Operating Expenses stood at $2.6 million, which was down 1408.59% from $3.0 million recorded in Q2 2025.
  • In the past 5 years, InfuSystem Holdings' Other Operating Expenses ranged from a high of $4.1 million in Q1 2022 and a low of $1.0 million during Q2 2021
  • Its 5-year average for Other Operating Expenses is $3.3 million, with a median of $3.3 million in 2021.
  • In the last 5 years, InfuSystem Holdings' Other Operating Expenses tumbled by 7325.67% in 2021 and then surged by 27492.51% in 2022.
  • Quarter analysis of 5 years shows InfuSystem Holdings' Other Operating Expenses stood at $3.9 million in 2021, then dropped by 12.63% to $3.4 million in 2022, then increased by 16.04% to $4.0 million in 2023, then crashed by 39.78% to $2.4 million in 2024, then increased by 8.09% to $2.6 million in 2025.
  • Its Other Operating Expenses stands at $2.6 million for Q3 2025, versus $3.0 million for Q2 2025 and $3.2 million for Q1 2025.